CorMedix Inc. short interest in 2021
In 2021, CorMedix Inc.'s disclosed short interest ran from 9.48% of shares outstanding on 15 Jan 2021 to 4.83% on 31 Dec 2021, a change of -4.65 percentage points. The year's high was 9.74% on 29 Jan 2021 and its low 4.83% on 31 Dec 2021, averaging 6.53% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.11 days on 31 Aug 2021. Full history: CorMedix Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 9.48% (15 Jan 2021)
- End of year
- 4.83% (31 Dec 2021)
- Change
- -4.65 pp
- High
- 9.74% (29 Jan 2021)
- Low
- 4.83% (31 Dec 2021)
- Average
- 6.53%
- Highest days to cover
- 12.11 (31 Aug 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 9.48% | 7.58 | |
| 29 Jan 2021 | 9.74% | 7.05 | |
| 12 Feb 2021 | 8.29% | 1.31 | |
| 26 Feb 2021 | 8.23% | 1.86 | |
| 15 Mar 2021 | 8.55% | 1.07 | |
| 31 Mar 2021 | 6.91% | 4.93 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 6.64% | 5.08 | |
| 30 Apr 2021 | 6.82% | 8.06 | |
| 14 May 2021 | 6.85% | 8.91 | 10-Q filed, results (8-K) |
| 28 May 2021 | 6.78% | 7.93 | |
| 15 Jun 2021 | 6.66% | 8.89 | |
| 30 Jun 2021 | 6.57% | 5.41 | |
| 15 Jul 2021 | 6.42% | 10.26 | |
| 30 Jul 2021 | 6.45% | 11.09 | |
| 13 Aug 2021 | 6.06% | 9.77 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 5.12% | 12.11 | |
| 15 Sep 2021 | 5.35% | 4.27 | |
| 30 Sep 2021 | 5.16% | 11.77 | |
| 15 Oct 2021 | 5.29% | 11.77 | |
| 29 Oct 2021 | 5.16% | 9.17 | |
| 15 Nov 2021 | 5.12% | 7.02 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 5.08% | 10.88 | |
| 15 Dec 2021 | 5.18% | 10.48 | |
| 31 Dec 2021 | 4.83% | 8.55 |
See also: CorMedix Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.